Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 0 | 47,380 | 31,548 | 28,060 | 49,247 |
| Cost of Goods | N/A | 40,158 | 26,718 | 26,646 | 42,851 |
| Gross Profit | N/A | 7,222 | 4,830 | 1,414 | 6,396 |
| Operating Expenses | 1,638 | 5,277 | 5,422 | 6,045 | 6,263 |
| Operating Income | -1,638 | 2,103 | 126 | -3,985 | 984 |
| Interest Expense | 0 | 1,040 | 864 | 933 | 1,429 |
| Other Income | 21 | 711 | -635 | 320 | -2,690 |
| Pre-tax Income | -1,617 | 1,774 | -1,373 | -4,598 | -3,135 |
| Income Tax | -4 | -195 | N/A | -281 | 173 |
| Net Income Continuous | -1,613 | 1,969 | -1,373 | -4,317 | -3,308 |
| Net Income Discontinuous | -1,651 | -810 | 1,056 | 2,484 | -2,912 |
| Net Income | $-3,264 | $1,159 | $-317 | $-1,833 | $-6,220 |
| EPS Basic Total Ops | -0.40 | 0.14 | -0.04 | -0.22 | -0.77 |
| EPS Basic Continuous Ops | -0.20 | 0.24 | -0.17 | -0.53 | -0.41 |
| EPS Basic Discontinuous Ops | -0.20 | -0.10 | 0.13 | 0.31 | -0.36 |
| EPS Diluted Total Ops | -0.40 | 0.14 | -0.04 | -0.22 | -0.77 |
| EPS Diluted Continuous Ops | -0.20 | 0.24 | -0.17 | -0.53 | -0.41 |
| EPS Diluted Discontinuous Ops | -0.20 | -0.10 | 0.13 | 0.31 | -0.36 |
| EBITDA(a) | $-3,583 | $3,156 | $1,142 | $-3,406 | $2,850 |